International Marijuana Business News

Aphria secures CA$100 million injection from anonymous investor

Canadian cannabis producer Aphria said Friday it has entered into an agreement with an institutional investor for a strategic investment worth 100 million Canadian dollars ($76 million). Chief Corporate Affairs Officer Tamara Macgregor told Marijuana Business Daily the investor requested to remain anonymous. The investor agreed to purchase just over 14 million Aphria units at CA$7.12 apiece. […]

Read More

No edibles under New Zealand’s medical cannabis scheme, government says

Businesses will be barred from marketing cannabis edibles under New Zealand’s medical program, which kicks off in April, the government confirmed to Marijuana Business Daily, eliminating for now the opportunity for companies to capitalize on what could be a sizable market. Some businesses had believed that doctors would be allowed to prescribe edibles. A Health […]

Read More

Report: Thailand issues 442 medical cannabis licenses, but full market access years away

Thailand is on track to be competitive in the nascent Asian medical marijuana and hemp markets, but the full commercialization of the sector and liberal access for private businesses is not likely to be implemented before 2024, according to a new report. The country’s medical cannabis market is characterized by high potential, fast regulatory developments […]

Read More

German pharmacies have new pharmaceutical CBD supplier

The medical cannabidiol market is becoming more competitive in Germany, as 2020 kicks off with one new CBD option that pharmacists can dispense to patients. A Cologne, Germany-based distributor of medical cannabis started offering pure CBD in kits with which pharmacists can compound preparations according to a doctor’s prescription. The kits allow pharmacists to prepare […]

Read More

Aurora Cannabis offshoot Australis Capital announces CFO departure

Australis Capital, an investment group that spun off from Canada’s Aurora Cannabis, announced the departure of Chief Financial Officer Michael Carlotti. In a brief news release issued after market close on Jan. 17, Las Vegas-based Australis said Carlotti’s employment had been “terminated” effective Jan. 16. The company gave no explanation for the move. Alex Han will […]

Read More

Aphria One, Brampton subsidiary receive EU-GMP certifications, clearing way for European cannabis exports

Aphria has received its first two essential European quality standard certifications, which the Canadian medical cannabis producer says will allow it to export finished dried flower and oil in bulk to European Union countries with established medical marijuana regimes. The company earned a certificate of EU-Good Manufacturing Practice (GMP) compliance on Jan. 15 for its […]

Read More

New Zealand to overturn cannabis vaporizer ban, clearing the way for imports

New Zealand plans to reverse a law banning cannabis vaporizers before new regulations kick in for the launch of the country’s medical program in April, Marijuana Business Daily has learned. “Currently, vaporizers are prohibited under the Misuse of Drugs (Prohibition of Cannabis Utensils and Methamphetamine Utensils) Notice,” a Health Ministry spokesperson told MJBizDaily. The “cabinet has […]

Read More

Analyst: Most Canadian marijuana firms not ready for next wave of products

The majority of Canadian cannabis companies were not ready for the launch of new cannabis products such as edibles, extracts and topicals, despite having more than a year to prepare for the Cannabis 2.0 era, according to an analyst. Only 10 companies had products available when Ontario’s only legal online store started selling the products […]

Read More

European Commission falls short on WHO cannabis recommendations, experts say

The European Commission’s proposal that European Union-member countries support three of the six World Health Organization (WHO) cannabis scheduling recommendations does not merit much celebration from the cannabis industry, according to international drug policy experts. “The only good point in the draft’s common position is that the EU should support the deletion of cannabis from Schedule IV, but […]

Read More